APA (7th ed.) Citation

Hitsman, B., Papandonatos, G. D., Gollan, J. K., Huffman, M. D., Niaura, R., Mohr, D. C., . . . Schnoll, R. A. (2023). Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo‐controlled trial. Addiction, 118(9), 1710. https://doi.org/10.1111/add.16209

Chicago Style (17th ed.) Citation

Hitsman, Brian, et al. "Efficacy and Safety of Combination Behavioral Activation for Smoking Cessation and Varenicline for Treating Tobacco Dependence Among Individuals with Current or Past Major Depressive Disorder: A 2 × 2 Factorial, Randomized, Placebo‐controlled Trial." Addiction 118, no. 9 (2023): 1710. https://doi.org/10.1111/add.16209.

MLA (9th ed.) Citation

Hitsman, Brian, et al. "Efficacy and Safety of Combination Behavioral Activation for Smoking Cessation and Varenicline for Treating Tobacco Dependence Among Individuals with Current or Past Major Depressive Disorder: A 2 × 2 Factorial, Randomized, Placebo‐controlled Trial." Addiction, vol. 118, no. 9, 2023, p. 1710, https://doi.org/10.1111/add.16209.